BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24673568)

  • 1. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.
    McCrudden MT; Torrisi BM; Al-Zahrani S; McCrudden CM; Zaric M; Scott CJ; Kissenpfennig A; McCarthy HO; Donnelly RF
    J Pharm Pharmacol; 2015 Mar; 67(3):409-25. PubMed ID: 24673568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
    Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
    Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery.
    Pamornpathomkul B; Ngawhirunpat T; Tekko IA; Vora L; McCarthy HO; Donnelly RF
    Eur J Pharm Sci; 2018 Aug; 121():200-209. PubMed ID: 29777854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.
    Migalska K; Morrow DI; Garland MJ; Thakur R; Woolfson AD; Donnelly RF
    Pharm Res; 2011 Aug; 28(8):1919-30. PubMed ID: 21437789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fast-dissolving microneedle array loaded with chitosan nanoparticles to evoke systemic immune responses in mice.
    Li Z; He Y; Deng L; Zhang ZR; Lin Y
    J Mater Chem B; 2020 Jan; 8(2):216-225. PubMed ID: 31803892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-fractional epidermal powder delivery for improved skin vaccination.
    Chen X; Kositratna G; Zhou C; Manstein D; Wu MX
    J Control Release; 2014 Oct; 192():310-6. PubMed ID: 25135790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: A proof of concept study.
    Rodgers AM; McCrudden MTC; Vincente-Perez EM; Dubois AV; Ingram RJ; Larrañeta E; Kissenpfennig A; Donnelly RF
    Int J Pharm; 2018 Oct; 549(1-2):87-95. PubMed ID: 30048778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination.
    Balmert SC; Carey CD; Falo GD; Sethi SK; Erdos G; Korkmaz E; Falo LD
    J Control Release; 2020 Jan; 317():336-346. PubMed ID: 31756393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.
    McCrudden MT; Alkilani AZ; McCrudden CM; McAlister E; McCarthy HO; Woolfson AD; Donnelly RF
    J Control Release; 2014 Apr; 180(100):71-80. PubMed ID: 24556420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique.
    Donnelly RF; Majithiya R; Singh TR; Morrow DI; Garland MJ; Demir YK; Migalska K; Ryan E; Gillen D; Scott CJ; Woolfson AD
    Pharm Res; 2011 Jan; 28(1):41-57. PubMed ID: 20490627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing intradermal delivery of tofacitinib citrate: Comparison between powder-loaded hollow microneedle arrays and dissolving microneedle arrays.
    Cárcamo-Martínez Á; Mallon B; Anjani QK; Domínguez-Robles J; Utomo E; Vora LK; Tekko IA; Larrañeta E; Donnelly RF
    Int J Pharm; 2021 Jan; 593():120152. PubMed ID: 33301867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
    Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
    J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays.
    Garland MJ; Migalska K; Tuan-Mahmood TM; Raghu Raj Singh T; Majithija R; Caffarel-Salvador E; McCrudden CM; McCarthy HO; David Woolfson A; Donnelly RF
    Int J Pharm; 2012 Sep; 434(1-2):80-9. PubMed ID: 22669101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacterium.
    de Groot AM; Du G; Mönkäre J; Platteel ACM; Broere F; Bouwstra JA; Sijts AJAM
    J Control Release; 2017 Nov; 266():27-35. PubMed ID: 28917531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Hydrogel-Forming Microneedle Array for Intradermal Vaccination in Mice Using Ovalbumin as a Model Protein Antigen.
    Courtenay AJ; Rodgers AM; McCrudden MTC; McCarthy HO; Donnelly RF
    Mol Pharm; 2019 Jan; 16(1):118-127. PubMed ID: 30452868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium.
    Gomaa YA; Garland MJ; McInnes F; El-Khordagui LK; Wilson C; Donnelly RF
    Eur J Pharm Biopharm; 2012 Oct; 82(2):299-307. PubMed ID: 22836025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameter optimization toward optimal microneedle-based dermal vaccination.
    van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
    Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.